• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medison to market flagship scanner

Article

The Food and Drug Administration has put the final regulatory pieces together for South Koreanultrasound vendor Medison. After a rather prolonged wait, theagency cleared Medison's SonoAce 4800 scanner, a gray-scale Dopplersystem that will be Medison's

The Food and Drug Administration has put the final regulatory pieces together for South Koreanultrasound vendor Medison. After a rather prolonged wait, theagency cleared Medison's SonoAce 4800 scanner, a gray-scale Dopplersystem that will be Medison's premium scanner until the introductionof a color-flow Doppler unit some time in the future, accordingto Mark Hayward, president of Medison's U.S. subsidiary in Pleasanton,CA. Two other Medison systems were cleared last year, with SonoAce4800 the last of the vendor's scanners in the FDA's review process(SCAN 2/2/94).

SonoAce 4800 is a convex, linear, mechanical and pulsed Dopplersystem that will be targeted at vascular and abdominal applications.Medison will handle direct sales and will market the system primarilyto the in-office ultrasound market. List price of SonoAce 4800with Doppler, two probes and a printer is $38,900. Medison marketsa color-flow Doppler unit in Korea and plans to bring that scannerto the U.S., Hayward said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.